| Multiple Sclerosis South Africa (MSSA) represents patient interests by advocating for access to affordable, effective MS treatments and by contributing the patient voice to policy, access, and reimbursement discussions. While MSSA does not set or negotiate drug prices, we engage with regulators, policymakers, and advisory bodies to highlight the real-world impact of pricing and access decisions on people living with MS, particularly in a South African and broader African context. | 神经系统
> 多发性硬化症 | 监管合作伙伴关系
> 与监管机构合作 | 5,000 | Regional | Regularly | 119035905477 |
| We are founder members of the SA [South Africa] NCD [Non-Communicable Disease] Alliance. | 内分泌
> 糖尿病和高血压 | 监管合作伙伴关系
> 与其他医疗保健倡导者 | 10,000 | National | Sometimes | 119045009637 |
| We are one of three founding members of the South African Non-Communicable Disease Association. | 内分泌
> 糖尿病和高血压 | 监管合作伙伴关系
> 与其他医疗保健倡导者 | 10,000 | National | Sometimes | 119051187994 |
| Multiple Sclerosis South Africa (MSSA) represents patient interests by advocating for access to affordable, effective MS [Multiple Sclerosis] treatments and by contributing the patient voice to policy, access, and reimbursement discussions. | 神经系统
> 多发性硬化症 | 影响政策和立法
> 影响医疗保健政策和立法 | 5,000 | Regional | Regularly | 119035905477 |
| CANSA [Cancer Association of South Africa] engages in policy advocacy, stakeholder consultations, and public submissions to promote equitable access to cancer prevention, diagnosis, and treatment. | 癌症
> 癌症：大多数类型 | 影响政策和立法
> 影响医疗保健政策和立法 | 10,000 | National | Regularly | 119044111428 |
| CANSA engages in policy advocacy, stakeholder consultations, and public submissions to promote equitable access to cancer prevention, diagnosis, and treatment. This includes contributing patient-centred perspectives on medicine access, reimbursement, and health system barriers through engagements with national health authorities, regulatory processes, and multi-stakeholder forums. Examples include: advocacy and submissions related to improving access to essential cancer medicines and diagnostics within the public health system; participation in consultative processes and policy discussions that inform regulatory and pricing frameworks impacting oncology treatments. | 癌症
> 癌症：大多数类型 | 影响政策和立法
> 参与公众听证会和咨询 | 10,000 | National | Regularly | 119044111428 |
| Multiple Sclerosis South Africa (MSSA) represents patient interests by advocating for access to affordable, effective MS [Multiple Sclerosis] treatments and by contributing the patient voice to policy, access, and reimbursement discussions. | 神经系统
> 多发性硬化症 | 定价与可负担性倡导
> 倡导公平的药品定价 | 5,000 | Regional | Regularly | 119035905477 |
| We often have to advocate for patients drug pricing, treatment baskets, and lists. | 风湿性
> 轴性脊柱关节炎 | 定价与可负担性倡导
> 倡导公平的药品定价 | Over 100,000 | National | Regularly | 119051166861 |
| CANSA engages in policy advocacy, stakeholder consultations, and public submissions to promote equitable access to cancer prevention, diagnosis, and treatment. This includes contributing patient-centred perspectives on medicine access, reimbursement, and health system barriers through engagements with national health authorities, regulatory processes, and multi-stakeholder forums. Examples include: advocacy and submissions related to improving access to essential cancer medicines and diagnostics within the public health system; participation in consultative processes and policy discussions that inform regulatory and pricing frameworks impacting oncology treatments. | 癌症
> 癌症：大多数类型 | 定价与可负担性倡导
> 参与价格审查委员会谈判 | 10,000 | National | Regularly | 119044111428 |
| CANSA engages in policy advocacy, stakeholder consultations, and public submissions to promote equitable access to cancer prevention, diagnosis, and treatment. This includes contributing patient-centred perspectives on medicine access, reimbursement, and health system barriers through engagements with national health authorities, regulatory processes, and multi-stakeholder forums. Examples include: advocacy and submissions related to improving access to essential cancer medicines and diagnostics within the public health system; participation in consultative processes and policy discussions that inform regulatory and pricing frameworks impacting oncology treatments. | 癌症
> 癌症：大多数类型 | 定价与可负担性倡导
> 倡导将产品纳入报销目录/国家处方集 | 10,000 | National | Regularly | 119044111428 |
| We often have to advocate for patients drug pricing, treatment baskets, and lists. | 风湿性
> 轴性脊柱关节炎 | 定价与可负担性倡导
> 倡导将产品纳入报销目录/国家处方集 | Over 100,000 | National | Regularly | 119051166861 |
| Multiple Sclerosis South Africa (MSSA) represents patient interests by advocating for access to affordable, effective MS [Multiple Sclerosis] treatments and by contributing the patient voice to policy, access, and reimbursement discussions. | 神经系统
> 多发性硬化症 | 改善访问路径
> 促进公平获取药品/医疗保健 | 5,000 | Regional | Regularly | 119035905477 |
| CANSA [Cancer Association of South Africa] engages in policy advocacy, stakeholder consultations, and public submissions to promote equitable access to cancer prevention, diagnosis, and treatment. | 癌症
> 癌症：大多数类型 | 改善访问路径
> 促进公平获取药品/医疗保健 | 10,000 | National | Regularly | 119044111428 |
| CANSA engages in policy advocacy, stakeholder consultations, and public submissions to promote equitable access to cancer prevention, diagnosis, and treatment. This includes contributing patient-centred perspectives on medicine access, reimbursement, and health system barriers through engagements with national health authorities, regulatory processes, and multi-stakeholder forums. Examples include: advocacy and submissions related to improving access to essential cancer medicines and diagnostics within the public health system; participation in consultative processes and policy discussions that inform regulatory and pricing frameworks impacting oncology treatments. | 癌症
> 癌症：大多数类型 | 循证患者意见
> 利用患者洞察来指导决策 | 10,000 | National | Regularly | 119044111428 |
| Multiple Sclerosis South Africa (MSSA) represents patient interests by advocating for access to affordable, effective MS treatments and by contributing the patient voice to policy, access, and reimbursement discussions. While MSSA does not set or negotiate drug prices, we engage with regulators, policymakers, and advisory bodies to highlight the real-world impact of pricing and access decisions on people living with MS, particularly in a South African and broader African context. | 神经系统
> 多发性硬化症 | 循证患者意见
> 向监管机构提供真实世界证据（RWE） | 5,000 | Regional | Regularly | 119035905477 |
| Multiple Sclerosis South Africa (MSSA) represents patient interests by advocating for access to affordable, effective MS treatments and by contributing the patient voice to policy, access, and reimbursement discussions. Our input is informed by lived experience, patient-reported challenges, and international collaboration through global MS networks, ensuring that patient needs, equity, and sustainability are considered in decision-making processes. | 神经系统
> 多发性硬化症 | 循证患者意见
> 利用患者故事和亲身经历叙述 | 5,000 | Regional | Regularly | 119035905477 |
| Have engaged the Department of Health. | 稀有
> 罕见病：免疫 | 机构治理
> 确保在政府咨询机构中的代表性 | 100 | International | Rarely | 119036013383 |
| Multiple Sclerosis South Africa (MSSA) represents patient interests by advocating for access to affordable, effective MS treatments and by contributing the patient voice to policy, access, and reimbursement discussions. While MSSA does not set or negotiate drug prices, we engage with regulators, policymakers, and advisory bodies to highlight the real-world impact of pricing and access decisions on people living with MS, particularly in a South African and broader African context. | 神经系统
> 多发性硬化症 | 机构治理
> 在多利益相关方网络中高效协作 | 5,000 | Regional | Regularly | 119035905477 |
| We are founder members of the SA [South Africa] NCD [Non-Communicable Disease] Alliance. | 内分泌
> 糖尿病和高血压 | 机构治理
> 维持公益或慈善实体的正式地位 | 10,000 | National | Sometimes | 119045009637 |
互动
行动与倡导
3 提及
